Conduent (CNDT) Competitors

$1.55 +0.16 (+11.51%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$1.54 -0.01 (-0.32%)

As of 05/18/2026 07:47 PM Eastern

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

Should you buy Conduent stock or one of its competitors? MarketBeat compares Conduent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conduent include Upwork (UPWK), Donnelley Financial Solutions (DFIN), LegalZoom.com (LZ), GoodRx (GDRX), and Nutex Health (NUTX). These companies are all part of the "business services" industry.

How does Conduent compare to Upwork?

Upwork (NASDAQ:UPWK) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

In the previous week, Upwork had 2 more articles in the media than Conduent. MarketBeat recorded 16 mentions for Upwork and 14 mentions for Conduent. Conduent's average media sentiment score of 0.47 beat Upwork's score of -0.04 indicating that Conduent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Upwork	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Upwork has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than Upwork, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upwork	$787.78M	1.37	$115.43M	$0.81	10.80
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

Upwork has a net margin of 13.81% compared to Conduent's net margin of -5.04%. Upwork's return on equity of 17.92% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Upwork	13.81%	17.92%	8.54%
Conduent	-5.04%	-7.08%	-2.04%

Upwork has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market. Comparatively, Conduent has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

77.7% of Upwork shares are held by institutional investors. Comparatively, 77.3% of Conduent shares are held by institutional investors. 7.6% of Upwork shares are held by company insiders. Comparatively, 1.9% of Conduent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Upwork presently has a consensus price target of $16.20, suggesting a potential upside of 85.14%. Given Upwork's higher probable upside, equities analysts clearly believe Upwork is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upwork	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Upwork beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to Donnelley Financial Solutions?

Conduent (NASDAQ:CNDT) and Donnelley Financial Solutions (NYSE:DFIN) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

Donnelley Financial Solutions has lower revenue, but higher earnings than Conduent. Conduent is trading at a lower price-to-earnings ratio than Donnelley Financial Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A
Donnelley Financial Solutions	$767M	1.28	$32.40M	$1.29	30.42

77.3% of Conduent shares are owned by institutional investors. Comparatively, 93.8% of Donnelley Financial Solutions shares are owned by institutional investors. 1.9% of Conduent shares are owned by insiders. Comparatively, 5.2% of Donnelley Financial Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Conduent had 10 more articles in the media than Donnelley Financial Solutions. MarketBeat recorded 14 mentions for Conduent and 4 mentions for Donnelley Financial Solutions. Conduent's average media sentiment score of 0.47 beat Donnelley Financial Solutions' score of 0.47 indicating that Conduent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Donnelley Financial Solutions	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Donnelley Financial Solutions has a net margin of 4.52% compared to Conduent's net margin of -5.04%. Donnelley Financial Solutions' return on equity of 24.80% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	-5.04%	-7.08%	-2.04%
Donnelley Financial Solutions	4.52%	24.80%	11.99%

Donnelley Financial Solutions has a consensus target price of $59.50, suggesting a potential upside of 51.61%. Given Donnelley Financial Solutions' higher probable upside, analysts plainly believe Donnelley Financial Solutions is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Donnelley Financial Solutions	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Conduent has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Donnelley Financial Solutions has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Summary

Donnelley Financial Solutions beats Conduent on 11 of the 17 factors compared between the two stocks.

How does Conduent compare to LegalZoom.com?

LegalZoom.com (NASDAQ:LZ) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

LegalZoom.com has a net margin of 1.46% compared to Conduent's net margin of -5.04%. LegalZoom.com's return on equity of 11.53% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LegalZoom.com	1.46%	11.53%	3.93%
Conduent	-5.04%	-7.08%	-2.04%

LegalZoom.com has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than LegalZoom.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LegalZoom.com	$779.71M	1.45	$15.43M	$0.06	109.67
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

In the previous week, Conduent had 1 more articles in the media than LegalZoom.com. MarketBeat recorded 14 mentions for Conduent and 13 mentions for LegalZoom.com. LegalZoom.com's average media sentiment score of 0.78 beat Conduent's score of 0.47 indicating that LegalZoom.com is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LegalZoom.com	3 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LegalZoom.com has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market. Comparatively, Conduent has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

LegalZoom.com presently has a consensus price target of $9.25, suggesting a potential upside of 40.58%. Given LegalZoom.com's higher possible upside, equities research analysts plainly believe LegalZoom.com is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LegalZoom.com	3 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

82.0% of LegalZoom.com shares are owned by institutional investors. Comparatively, 77.3% of Conduent shares are owned by institutional investors. 5.9% of LegalZoom.com shares are owned by insiders. Comparatively, 1.9% of Conduent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

LegalZoom.com beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

GoodRx presently has a consensus target price of $3.81, indicating a potential upside of 52.50%. Given GoodRx's higher probable upside, analysts clearly believe GoodRx is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

GoodRx has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.67
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

In the previous week, Conduent had 10 more articles in the media than GoodRx. MarketBeat recorded 14 mentions for Conduent and 4 mentions for GoodRx. GoodRx's average media sentiment score of 0.99 beat Conduent's score of 0.47 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	0 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.8% of GoodRx shares are held by institutional investors. Comparatively, 77.3% of Conduent shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 1.9% of Conduent shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

GoodRx has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Conduent has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

GoodRx has a net margin of 2.61% compared to Conduent's net margin of -5.04%. GoodRx's return on equity of 7.90% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
Conduent	-5.04%	-7.08%	-2.04%

Summary

GoodRx beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to Nutex Health?

Conduent (NASDAQ:CNDT) and Nutex Health (NASDAQ:NUTX) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Conduent has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market. Comparatively, Nutex Health has a beta of 0.25, suggesting that its stock price is 75% less volatile than the broader market.

Nutex Health has a net margin of 10.95% compared to Conduent's net margin of -5.04%. Nutex Health's return on equity of 23.50% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	-5.04%	-7.08%	-2.04%
Nutex Health	10.95%	23.50%	10.47%

Nutex Health has lower revenue, but higher earnings than Conduent. Conduent is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A
Nutex Health	$875.26M	0.98	$70.79M	$12.94	9.64

77.3% of Conduent shares are held by institutional investors. Comparatively, 5.3% of Nutex Health shares are held by institutional investors. 1.9% of Conduent shares are held by insiders. Comparatively, 44.7% of Nutex Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Conduent had 13 more articles in the media than Nutex Health. MarketBeat recorded 14 mentions for Conduent and 1 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.93 beat Conduent's score of 0.47 indicating that Nutex Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutex Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutex Health has a consensus price target of $205.00, suggesting a potential upside of 64.39%. Given Nutex Health's higher probable upside, analysts plainly believe Nutex Health is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Nutex Health	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Nutex Health beats Conduent on 11 of the 17 factors compared between the two stocks.

Get Conduent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNDT vs. The Competition

Export

Metric	Conduent	Outsourcing Industry	Business Sector	NASDAQ Exchange
Market Cap	$215.59M	$3.34B	$6.42B	$12.29B
Dividend Yield	N/A	2.14%	3.20%	5.30%
P/E Ratio	-1.52	9.56	30.02	25.23
Price / Sales	0.08	0.65	421.98	74.61
Price / Cash	1.59	6.29	22.13	37.30
Price / Book	0.35	6.99	6.02	6.63
Net Income	-$170M	$263.73M	$205.07M	$335.59M
7 Day Performance	4.03%	-2.15%	2.48%	-1.20%
1 Month Performance	-4.91%	-15.08%	-4.10%	-1.16%
1 Year Performance	-30.18%	-36.41%	29.30%	28.10%

Conduent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNDT Conduent	2.8325 of 5 stars	$1.55 +11.5%	N/A	-31.1%	$215.59M	$3.04B	N/A	51,000	Earnings Report
UPWK Upwork	4.0116 of 5 stars	$8.81 -0.1%	$16.20 +83.9%	-49.2%	$1.09B	$787.78M	10.88	850
DFIN Donnelley Financial Solutions	4.0199 of 5 stars	$41.91 -2.2%	$59.50 +42.0%	-28.9%	$1.07B	$767M	32.49	1,750
LZ LegalZoom.com	4.2237 of 5 stars	$6.10 -0.5%	$9.25 +51.6%	-29.2%	$1.05B	$756.04M	101.68	1,196
GDRX GoodRx	4.4177 of 5 stars	$2.84 -2.7%	$3.77 +32.8%	-36.9%	$1.00B	$787.89M	47.34	950	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNDT) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conduent (CNDT) Competitors

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

How does Conduent compare to Upwork?

Summary

How does Conduent compare to Donnelley Financial Solutions?

Summary

How does Conduent compare to LegalZoom.com?

Summary

How does Conduent compare to GoodRx?

Summary

How does Conduent compare to Nutex Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNDT vs. The Competition

Conduent Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conduent (CNDT) Competitors

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

How does Conduent compare to Upwork?

Does the media prefer UPWK or CNDT?

Which has preferable earnings & valuation, UPWK or CNDT?

Is UPWK or CNDT more profitable?

Which has more risk and volatility, UPWK or CNDT?

Do insiders and institutionals believe in UPWK or CNDT?

Do analysts prefer UPWK or CNDT?

Summary

How does Conduent compare to Donnelley Financial Solutions?

Which has preferable valuation & earnings, CNDT or DFIN?

Do institutionals & insiders hold more shares of CNDT or DFIN?

Does the media refer more to CNDT or DFIN?

Is CNDT or DFIN more profitable?

Do analysts prefer CNDT or DFIN?

Which has more risk & volatility, CNDT or DFIN?

Summary

How does Conduent compare to LegalZoom.com?

Is LZ or CNDT more profitable?

Which has better earnings & valuation, LZ or CNDT?

Does the media prefer LZ or CNDT?

Which has more volatility and risk, LZ or CNDT?

Do analysts recommend LZ or CNDT?

Do institutionals and insiders hold more shares of LZ or CNDT?

Summary

How does Conduent compare to GoodRx?

Do analysts prefer GDRX or CNDT?

Which has preferable earnings & valuation, GDRX or CNDT?

Does the media favor GDRX or CNDT?

Do insiders and institutionals believe in GDRX or CNDT?

Which has more volatility and risk, GDRX or CNDT?

Is GDRX or CNDT more profitable?

Summary

How does Conduent compare to Nutex Health?

Which has more risk and volatility, CNDT or NUTX?

Is CNDT or NUTX more profitable?

Which has better valuation & earnings, CNDT or NUTX?

Do insiders and institutionals have more ownership in CNDT or NUTX?

Does the media favor CNDT or NUTX?

Do analysts rate CNDT or NUTX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNDT vs. The Competition

Conduent Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools